Katja Fink

ABOUT

Katja Fink has studied how patients’ immune systems react to dengue infection for more than ten years after moving to Singapore from Switzerland. Together with her team at the Agency for Science, Technology and Research (A*STAR), she is working on immunotherapies for dengue, including vaccines and antibodies. She also teaches at Nanyang Technological University as an Adjunct Assistant Professor.